Chan, Yinghan 
; MacLoughlin, Ronan ; Tambuwala, Murtaza M ; Pabari, Ritesh M ; Singh, Sachin Kumar ; Pinto, Terezinha de Jesus Andreoli ; Gupta, Gaurav ; Chellappan, Dinesh Kumar ; Dua, Kamal
Source: Nanomedicine. Unidade: FCF
Subjects: DOENÇAS RESPIRATÓRIAS, NANOTECNOLOGIA, INFLAMAÇÃO, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAN, Yinghan et al. Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases. Nanomedicine, v. 16, n. 16, p. 1351–1355, 2021Tradução . . Disponível em: https://doi.org/10.2217/nnm-2021-0087. Acesso em: 05 nov. 2024.APA
Chan, Y., MacLoughlin, R., Tambuwala, M. M., Pabari, R. M., Singh, S. K., Pinto, T. de J. A., et al. (2021). Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases. Nanomedicine, 16( 16), 1351–1355. doi:10.2217/nnm-2021-0087NLM
Chan Y, MacLoughlin R, Tambuwala MM, Pabari RM, Singh SK, Pinto T de JA, Gupta G, Chellappan DK, Dua K. Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases [Internet]. Nanomedicine. 2021 ; 16( 16): 1351–1355.[citado 2024 nov. 05 ] Available from: https://doi.org/10.2217/nnm-2021-0087Vancouver
Chan Y, MacLoughlin R, Tambuwala MM, Pabari RM, Singh SK, Pinto T de JA, Gupta G, Chellappan DK, Dua K. Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases [Internet]. Nanomedicine. 2021 ; 16( 16): 1351–1355.[citado 2024 nov. 05 ] Available from: https://doi.org/10.2217/nnm-2021-0087
